Remember meForgot password?
    Log in with Twitter

Bayer News

Monsanto ordered to pay $2 bn in latest Roundup blow

San Francisco - In a third major legal blow to Bayer-owned Monsanto and its weedkiller Roundup, a jury in California has ordered the chemicals giant to pay more than $2 billion in damages to a couple that sued on grounds the product caused their cancer, lawyers said.

Bayer shareholders vote against board over Monsanto merger

Bonn - Bayer chief executive Werner Baumann was dealt a blow Friday at the German chemical giant's annual general meeting, amid tensions over last year's decision to buy US seeds and pesticides maker Monsanto, as disgruntled shareholders voted against managem...

Bayer applies artificial intelligence to medical cases

Major pharmaceutical firm Bayer is exploring how artificial intelligence can be used to assess case reports relating to adverse drug events in relation to its medicines.

Bayer shares tumble on Monsanto's Roundup cancer verdict

Bayer shares plunged as much as 14 percent on Monday, losing about $14 billion in value after newly acquired Monsanto was ordered to pay $289 million in damages to a man who said ingredients used in the weedkiller had caused his cancer.

Bayer-Monsanto merger creates agrichemical juggernaut

Frankfurt Am Main - German chemicals and pharmaceuticals giant Bayer will seal a $63-billion merger with US-based Monsanto Thursday, creating an agrichemical behemoth with lofty ambitions to feed the world but lambasted by environmentalists.

Bayer to ditch Monsanto name after mega-merger

Frankfurt Am Main - German chemicals and pharmaceuticals giant Bayer will discard the name Monsanto when it takes over the controversial US seeds and pesticides producer this week, it said Monday.

Bayer's Essure trial is approved again after FDA re-evaluation

The U.S. Food and Drug Administration (FDA) concluded its investigation on Essure's pivotal trial. Bayer, the company that manufactures the controversial contraception method, has been, in fact, accused of manipulating data to inflate the device's safety.

Bayer AG clinches deal to buyout Monsanto for $66 billion

German drug and farm chemical maker Bayer AG has finally reached a deal with U.S. seed and weed killer company Monsanto that could create a company that will control over a quarter of the world's market for seeds and pesticides.

Monsanto turns down Bayer's proposal, still open to negotiations

Monsanto has rejected a $62 billion takeover proposal from German pharmaceutical giant Bayer, calling the bid "incomplete and financially inadequate." However, negotiations still appear to be open.

Bayer-Monsanto tie-up fuels anti-GM debate in Germany

Frankfurt - A proposed tie-up between Bayer and Monsanto may still face numerous hurdles but it has already inflamed opinion in Germany where most people oppose genetically modified foods.

FDA issues Black Box warning for Essure — Lawsuits keep growing

A federal court ruled that 2 cases of women who claim they were harmed by Bayer's birth control device Essure can continue. In the meanwhile, the Food and Drug Administration (FDA) issued a "black box" label to warn the public about its dangerousness.

Bayer announces new Xarelto safety studies in diabetic patients

Janssen Pharmaceuticals and Bayer AG announced 13 data presentations at the American College of Cardiology (ACC). The studies will include real-world data about Xarelto safety in patients with diabetes and atrial fibrillation.

Bayer sued in Germany over contraceptive pill after health scares

Willst - "If I'd known, I'd never have taken this pill," says Felicitas Rohrer, who is suing German pharmaceuticals giant Bayer, claiming its oral contraceptive Yasminelle caused her to suffer a pulmonary embolism.

Bayer - no charge that probiotic is wrongfully promoted (update) Special

Washington - The U.S. Federal Trade Commission has accused drugs maker Bayer of illegally promoting the effect of its probiotic, a collection of bacteria that it says “support digestive health.” However, the Justice Department will not pursue the charge.

Bayer forges ahead with heart failure drug after positive results

Basking in its success with stroke prevention pill Xarelto and eye treatment Eylea, Bayer AG is anxious to show it has another winner in its heart drug, Finerenone. The German company is moving its heart failure drug into final-stage testing this year.

Lobby against bee-killing pesticides Special

Brussels - Activists and critical shareholders from Coordination Bayer Gefahren (CBG) and European beekeepers are demanding that Bayer drop its lawsuit against the European Commission over bee-killing pesticides.

Bayer optimistic after reporting profit jump in 2013

Frankfurt - German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said on Friday it was optimistic about business this year after meeting key targets in 2013."We met important business objectives in our anniversary year," chief executive Marijn Dekke...

Bayer says will buy Chinese over-the-counter drugs maker

Frankfurt - German pharmaceuticals giant Bayer, maker of Aspirin, said on Thursday it had signed an agreement to buy the privately-owned Chinese group Dihon Pharmaceutical for an undisclosed sum.Dihon specialises in prescription-free or over-the-counter (OTC) drug...

Bayer succeeds in buying Norway's Algeta

Frankfurt - German pharmaceuticals giant Bayer said Wednesday its 1.9-billion-euro ($2.6-billion) bid for Norwegian cancer treatment specialist Algeta has been successful and it now holds more than 97 percent in the firm."The way is now clear for the Bayer group t...

MSF slams Bayer for saving drugs for those who can pay

New Delhi - Global medical charity Medecins Sans Frontieres slammed Friday a statement by Bayer's chief executive that the giant German firm only developed its cancer drug Nexavar for people who could afford the medicine, not "for Indians".

Bayer seeks to halt India producing affordable medicines

The government of India has rejected a request by the pharmaceutical company Bayer AG that it desists with the manufacture of a cheaper generic version of its patented cancer drug.

Bayer buys Schiff for $1.2 billion

Bayer, a German pharmaceutical and chemical company, acquired vitamins maker Schiff Nutrition Inc. for around $1.2 billion.

FDA Sends Warning Letters to Bayer HealthCare

The U.S. Food and Drug Administration sent Warning Letters to Bayer HealthCare concerning two unlawful, over-the-counter (OTC) ASA products, Bayer Women's Low Dose Aspirin + Calcium (Bayer Women's) and (Bayer Heart Advantage).

22,000 Lives Lost Because Drug Recall Was Delayed

When U.S. regulators delayed recalling a Bayer AG drug it resulted in the deaths of 22,000 patients. The drug Trasylol was used to stem bleeding during open heart surgery. Last November it was finally withdrawn from the market.

Bayer's Aleve May Contribute To Heart Risk

Aleve, also known as naproxen, may cause a small increase in the risk of heart attacks and stroke.

Search Digital Journal Archives

Set up a news alert for


Bayer Image

Bayer factory in Leverkusen  Germany
Bayer factory in Leverkusen, Germany
A. Savin
Bayer HealthCare Pharmaceuticals/ Sellerstraße/Berlin-Wedding in Berlin-Mitte  Berlin (Germany)
Bayer HealthCare Pharmaceuticals/ Sellerstraße/Berlin-Wedding in Berlin-Mitte, Berlin (Germany)
Miriam Guterland
Bayer sign
Bayer sign
Yaz™ is trademarks of Bayer.

Latest News
Top News